全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy

DOI: 10.1186/bcr1358

Full-Text   Cite this paper   Add to My Lib

Abstract:

Although mammography is the primary clinical imaging modality used to detect breast cancer, limitations in both sensitivity and specificity, particularly in younger and high-risk women, have led to the development of alternative techniques. Overall, mammography has reduced sensitivity in pre-menopausal women [1] and is not clinically advantageous for women under 35 years of age [2]. A general consensus has emerged that mammography is not recommended for women less than 40 years of age, and in the 40 to 50 year old population there is uncertainly regarding its effectiveness. Additional complications arise due to the fact that in pre-menopausal women, mammographic density and false negative rates are greater during the luteal versus follicular phase of the menstrual cycle [3]. Similarly, the use of hormone replacement therapy in post-menopausal women is known to increase mammographic density [4] and has been shown to impede the effectiveness of mammographic screening [5,6]. In practical terms, up to 10% of all breast cancers, roughly 20,000 cases per year in the US, are not discovered by X-ray mammography [7]. Consequently, new detection technologies are needed that can overcome the limitations of high radiographic density.The use of near infrared (NIR) optical methods as a supplement to conventional techniques for diagnosing and detecting breast cancer has generated considerable interest. Optical methods are advantageous because they are non-invasive, fast, relatively inexpensive, pose no risk of ionizing radiation, and NIR light can easily penetrate centimeter-thick tissues. Several groups have employed optical methods to measure subtle physiological differences in healthy breast tissue [8-13], to detect tumors [14-22], and to measure tumor response to neoadjuvant chemotherapy [23-25]. Differences in optical signatures between tissues are manifestations of multiple physiological changes associated with factors such as vascularization, cellularity, oxygen consumption

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133